Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials

4370 results

Sort By:

A Study Investigating Coagadex in the Treatment AFXD Associated With AL Amyloidosis

Study ID: NCT06963216
Start Date: 2025-12
End Date: 2027-09
Study Type

Interventional

Study Phase

Phase3

No. of Participants

15

Intervention / Treatment

Coagadex(R)

Sponsor

Kedrion S.p.A.

Source: clinicaltrials.gov

Share:
Add to list

INitiation and Titration of Guideline Directed Medical TheRApy in HearT Failure Cardiogenic Shock With ImpElla 5.5 for Cardiac Recovery

Study ID: NCT06965504
Start Date: 2025-12-01
End Date: 2028-06-01
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

60

Intervention / Treatment

Impella 5.5 Smart Assist

Sponsor

Abiomed Inc.

Source: clinicaltrials.gov

Share:
Add to list

Evaluation of DPA for Treatment of Upper Anterior Crowding

Study ID: NCT06625658
Start Date: 2026-01-10
End Date: 2026-12
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

9

Intervention / Treatment

Direct printed clear aligners

Sponsor

Samia Omar

Source: clinicaltrials.gov

Share:
Add to list

Study of the Shockwave Medical SkyRunner Carotid Intravascular Lithotripsy (IVL) System for the Treatment of Calcified Carotid Arteries Prior to Trans-Carotid Stenting (SKYWARD Trans-Carotid IDE [Investigational Device Exemption] Study)

Study ID: NCT07062471
Start Date: 2026-01
End Date: 2029-06
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

160

Intervention / Treatment

Carotid Intravascular Lithotripsy (IVL)

Sponsor

Shockwave Medical, Inc.

Source: clinicaltrials.gov

Share:
Add to list

Horizon Two Adaptive Platform Study in High Risk Newly Diagnosed Multiple Myeloma

Study ID: NCT07053436
Start Date: 2025-10-01
End Date: 2035-10-12
Study Type

Interventional

Study Phase

Phase2

No. of Participants

300

Intervention / Treatment

Bispecific Monoclonal Antibody and Triplet Therapy

Monoclonal Antibody with Stem Cell Transplant

Sponsor

Multiple Myeloma Research Consortium

Source: clinicaltrials.gov

Share:
Add to list

Evaluation of the Safety, Efficacy, and Pharmacokinetics of NBM-BMX in Patients With Metastatic Uveal Melanoma

Study ID: NCT07136181
Start Date: 2025-10
End Date: 2029-05-30
Study Type

Interventional

Study Phase

Phase2

No. of Participants

36

Intervention / Treatment

NBM-BMX Capsule are proprietary products developed by Novelwise Pharmaceutical Corporation (Novelwise) for treatment of patients suffering from cancers.

Sponsor

Novelwise Pharmaceutical Corporation

Source: clinicaltrials.gov

Share:
Add to list

Study of Recurrence-directed Therapy (RDT) With or Without Androgen-Deprivation Therapy (ADT) In Patients With Radio-recurrent Oligo-metastatic Hormone/Castrate Sensitive Prostate Cancer (romCSPC)

Study ID: NCT06654336
Start Date: 2025-09-30
End Date: 2031-06
Study Type

Interventional

Study Phase

Phase2

No. of Participants

162

Intervention / Treatment

Recurrence-directed therapy (RDT)

ELIGARD 22.5mg

Sponsor

Ontario Clinical Oncology Group (OCOG)

Source: clinicaltrials.gov

Share:
Add to list

Dose Finding Trial of R21/Matrix-M in School Children

Study ID: NCT07074665
Start Date: 2025-10
End Date: 2026-12
Study Type

Interventional

Study Phase

Phase2

No. of Participants

40

Intervention / Treatment

5µg R21/50µg Matrix-M

10µg R21/50µg Matrix-M

Sponsor

University of Oxford

Source: clinicaltrials.gov

Share:
Add to list

The Effect of Laughter Yoga on Premenstrual Syndrome Symptoms and Quality of Life in Young Women

Study ID: NCT07139223
Start Date: 2025-09-29
End Date: 2025-11-30
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

72

Intervention / Treatment

laughter yoga

Sponsor

Lokman Hekim University

Source: clinicaltrials.gov

Share:
Add to list

Investigation of the Genetic and Environmental Causes of Autism: a Multi-Center Study

Study ID: NCT06662591
Start Date: 2025-12-27
End Date: 2028-05-27
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

3000

Intervention / Treatment
Sponsor

Research and Treatment Society of Genetic Disorders

Source: clinicaltrials.gov

Share:
Add to list